{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:56:29Z","timestamp":1781535389708,"version":"3.54.5"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["MH105231"],"award-info":[{"award-number":["MH105231"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["MH100974"],"award-info":[{"award-number":["MH100974"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI106039"],"award-info":[{"award-number":["AI106039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"crossref","award":["IN-US-292-4217"],"award-info":[{"award-number":["IN-US-292-4217"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Improved pre-exposure prophylaxis (PrEP) uptake is essential for human immunodeficiency virus (HIV) prevention initiatives. Offering PrEP at the time of HIV and sexually transmitted infection (STI) testing can improve uptake. We offered rapid PrEP initiation in a sexual health clinic and assessed predictors of PrEP interest, initiation, linkage, and retention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between November 2018 and February 2020, PrEP-eligible individuals who presented to a sexual health clinic were offered a free 30-day supply of PrEP plus linkage to continued PrEP care. Univariable and multivariable analyses of demographic and HIV risk data were conducted to determine predictors of PrEP uptake.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 1259 adults who were eligible for PrEP (99.7% male, 42.7% White, 36.2% Hispanic), 456 were interested in PrEP, 249 initiated PrEP, 209 were linked, and 67 were retained in care. Predictors of PrEP interest included younger age (P &amp;lt; .01), lower monthly income (P = .01), recreational drug use (P = .02), and a greater number of sexual partners (P &amp;lt; .01). Negative predictors of PrEP initiation included lower monthly income (P = .04), testing positive for chlamydia (P = .04), and exchanging money for sex (P = .01). Negative predictors of linkage included self-identifying as Black (P = .03) and testing positive for an STI (P &amp;lt; .01). Having health insurance positively predicted both linkage (P &amp;lt; .01) and retention (P &amp;lt; .03).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A minority of PrEP-eligible HIV and STI testers initiated PrEP when offered, suggesting that easy PrEP access in sexual health clinics alone may not improve uptake. Predictors of uptake included established HIV risk factors and markers of higher socioeconomic status, suggesting that those aware of their risk and with the means to utilize health services engaged best with this model.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ofid\/ofad060","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T09:22:41Z","timestamp":1675848161000},"source":"Crossref","is-referenced-by-count":8,"title":["Predictors of Human Immunodeficiency Virus Pre-Exposure Prophylaxis (PrEP) Uptake in a Sexual Health Clinic With Rapid PrEP Initiation"],"prefix":"10.1093","volume":"10","author":[{"given":"Gabriel A","family":"Wagner","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego , San Diego, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Sheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego , San Diego, California , USA"},{"name":"Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Veterans General Hospital , Kaohsiung City , Taiwan"},{"name":"Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University , Taipei , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Anderson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego , San Diego, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Burgi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego , San Diego, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J","family":"Little","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases & Global Public Health, Department of Medicine, University of California San Diego , San Diego, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok tenofovir study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25461","article-title":"National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017","volume":"23","author":"Sullivan","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"2023032309161641700_","author":"Centers for Disease Control and Prevention"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"801","DOI":"10.15585\/mmwr.mm6837a2","article-title":"Racial\/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men\u201423 urban areas, 2017","volume":"68","author":"Kanny","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1097\/QAD.0000000000002347","article-title":"Racial\/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics","volume":"33","author":"Scott","year":"2019","journal-title":"AIDS"},{"key":"2023032309161641700_","author":"Centers for Disease Control and Prevention"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2105\/AJPH.2018.304727","article-title":"Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006\u20132017","volume":"109","author":"Becasen","year":"2019","journal-title":"Am J Public Health"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2021-054121","article-title":"PrEP distribution in pharmacies: a systematic review","volume":"12","author":"Kennedy","year":"2022","journal-title":"BMJ Open"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"e1003492","DOI":"10.1371\/journal.pmed.1003492","article-title":"HIV Incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: a population-based study in rural Kenya and Uganda","volume":"18","author":"Koss","year":"2021","journal-title":"PLoS Med"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2019.0235","article-title":"A pharmacist-led, same-day, HIV Pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP initiation","volume":"34","author":"Khosropour","year":"2020","journal-title":"AIDS Patient Care STDS"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"ofz310","DOI":"10.1093\/ofid\/ofz310","article-title":"Same-day HIV pre-exposure prophylaxis (PrEP) initiation during drop-in sexually transmitted diseases clinic appointments is a highly acceptable, feasible, and safe model that engages individuals at risk for HIV into PrEP care","volume":"6","author":"Kamis","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2023032309161641700_","article-title":"PrEP initiation in a Washington D.C. sexual health clinic and linkage to primary care","author":"Coleman"},{"key":"2023032309161641700_","article-title":"Immediate PrEP initiation at New York City sexual health clinics","author":"Mikati","year":"2019"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2105\/AJPH.2019.305057","article-title":"Pharmacists in HIV prevention: an untapped potential","volume":"109","author":"Myers","year":"2019","journal-title":"Am J Public Health"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.japh.2020.01.026","article-title":"Community pharmacy delivered PrEP to STOP HIV transmission: an opportunity NOT to miss!","volume":"60","author":"Lopez","year":"2020","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/apc.2018.0294","article-title":"The pharmacist's expanding role in HIV pre-exposure prophylaxis","volume":"33","author":"Farmer","year":"2019","journal-title":"AIDS Patient Care STDS"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/OLQ.0000000000000882","article-title":"Impact of providing preexposure prophylaxis for human immunodeficiency virus at clinics for sexually transmitted infections in Baltimore city: an agent-based model","volume":"45","author":"Kasaie","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.japh.2019.06.021","article-title":"Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco department of public health","volume":"60","author":"Lopez","year":"2020","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"suppl_1","key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"S395","DOI":"10.1093\/ofid\/ofy210.1126","article-title":"1293. The next step in PrEP: evaluating outcomes of a pharmacist-run HIV pre-exposure prophylaxis (PrEP) clinic","volume":"5","author":"Ryan","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"ofz365","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis program in the midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2023032309161641700_","first-page":"e48","article-title":"Development of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis clinic at an urban community clinic","volume":"56","author":"Sawkin","year":"2016","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2023032309161641700_","author":"Tung","year":"2017"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"778","DOI":"10.7326\/0003-4819-152-12-201006150-00005","article-title":"Evaluation of an HIV nucleic acid testing program with automated internet and voicemail systems to deliver results","volume":"152","author":"Morris","year":"2010","journal-title":"Ann Intern Med"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/ciy558","article-title":"Performance of treponemal tests for the diagnosis of syphilis","volume":"68","author":"Park","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s10461-020-03111-w","article-title":"The role of pharmacies in the HIV prevention and care continuums: a systematic review","volume":"25","author":"Crawford","year":"2021","journal-title":"AIDS Behav"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1071\/SH18084","article-title":"Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care","volume":"15","author":"Tung","year":"2018","journal-title":"Sex Health"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/OLQ.0000000000000514","article-title":"Implementation of preexposure prophylaxis for human immunodeficiency virus prevention among men who have sex with men at a New England sexually transmitted diseases clinic","volume":"43","author":"Chan","year":"2016","journal-title":"Sex Transm Dis"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/QAI.0000000000002638","article-title":"Acute HIV at the time of initiation of pre-exposure or post-exposure prophylaxis: impact on drug resistance and clinical outcomes","volume":"87","author":"Johnson","year":"2021","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/COH.0000000000000734","article-title":"Key population perceptions and opinions about long-acting antiretrovirals for prevention and treatment: a scoping review","volume":"17","author":"Sued","year":"2022","journal-title":"Curr Opin HIV AIDS"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/OLQ.0000000000001017","article-title":"Iowa TelePrEP: a public-health-partnered telehealth model for human immunodeficiency virus preexposure prophylaxis delivery in a rural state","volume":"46","author":"Hoth","year":"2019","journal-title":"Sex Transm Dis"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/sextrans-2012-050648","article-title":"Who would use PrEP? Factors associated with intention to use among MSM in London: a community survey","volume":"89","author":"Aghaizu","year":"2013","journal-title":"Sex Transm Infect"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/QAD.0000000000000639","article-title":"What do Dutch MSM think of preexposure prophylaxis to prevent HIV-infection? A cross-sectional study","volume":"29","author":"Bil","year":"2015","journal-title":"AIDS"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0956462417730259","article-title":"Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UK","volume":"29","author":"Bull","year":"2017","journal-title":"Int J STD AIDS"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/sextrans-2015-052101","article-title":"Towards preparedness for PrEP: prEP awareness and acceptability among MSM at high risk of HIV transmission who use sociosexual media in four Celtic nations: Scotland, Wales, Northern Ireland and the Republic of Ireland: an online survey","volume":"92","author":"Frankis","year":"2016","journal-title":"Sex Transm Infect"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s10461-016-1516-5","article-title":"Awareness and willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil","volume":"21","author":"Hoagland","year":"2017","journal-title":"AIDS Behav"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/sextrans-2016-052774","article-title":"Willingness to use and have sex with men taking HIV pre-exposure prophylaxis (PrEP): results of online surveys of Australian gay and bisexual men, 2011\u20132015","volume":"93","author":"Holt","year":"2017","journal-title":"Sex Transm Infect"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"e015142","DOI":"10.1136\/bmjopen-2016-015142","article-title":"Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: a cross-sectional questionnaire survey","volume":"7","author":"Lee","year":"2017","journal-title":"BMJ Open"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10461-016-1466-y","article-title":"The \u201csafe sex\u201d conundrum: anticipated stigma from sexual partners as a barrier to PrEP use among substance using MSM engaging in transactional sex","volume":"21","author":"Biello","year":"2017","journal-title":"AIDS Behav"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1016\/S2468-2667(20)30186-9","article-title":"Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study","volume":"5","author":"Hanum","year":"2020","journal-title":"Lancet Public Health"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s12889-020-08498-8","article-title":"Associations of health literacy with socioeconomic position, health risk behavior, and health status: a large national population-based survey among Danish adults","volume":"20","author":"Svendsen","year":"2020","journal-title":"BMC Public Health"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/apc.2016.0037","article-title":"The promise of pre-exposure prophylaxis for black men who have sex with men: an ecological approach to attitudes, beliefs, and barriers","volume":"30","author":"Philbin","year":"2016","journal-title":"AIDS Patient Care STDS"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/09540121.2017.1300633","article-title":"Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts","volume":"29","author":"Cahill","year":"2017","journal-title":"AIDS Care"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/13691058.2017.1380230","article-title":"WTF Is PrEP?\u201d: attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City","volume":"20","author":"Thomann","year":"2018","journal-title":"Cult Health Sex"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s10461-017-1739-0","article-title":"Use of pre-exposure prophylaxis (PrEP) in young men who have sex with men is associated with race, sexual risk behavior and peer network size","volume":"21","author":"Kuhns","year":"2017","journal-title":"AIDS Behav"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1007\/s10461-019-02641-2","article-title":"The PrEP care continuum and black men who have sex with men: a scoping review of published data on awareness, uptake, adherence, and retention in PrEP care","volume":"23","author":"Ezennia","year":"2019","journal-title":"AIDS Behav"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s10461-017-2009-x","article-title":"HIV pre-exposure prophylaxis (PrEP) uptake and retention among men who have sex with men in a community-based sexual health clinic","volume":"22","author":"Hojilla","year":"2018","journal-title":"AIDS Behav"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/QAI.0000000000002712","article-title":"Reaching those most at risk for HIV acquisition: evaluating racial\/ethnic disparities in the preexposure prophylaxis care continuum in Baltimore City, Maryland","volume":"87","author":"Schumacher","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2023032309161641700_","article-title":"What's PrEP? Peer navigator acceptability among minority MSM in Washington","volume":"20(1):248","author":"Pagkas-Bather","year":"2020","journal-title":"BMC Public Health"},{"issue":"S1","key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"e25495","DOI":"10.1002\/jia2.25495","article-title":"Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study","volume":"23","author":"B\u00f3rquez","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"2023032309161641700_","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/cid\/cix1055","article-title":"Randomized controlled trial of daily text messages to support adherence to preexposure prophylaxis in individuals at risk for human immunodeficiency virus: the TAPIR study","volume":"66","author":"Moore","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023032309161641700_","author":"Centers for Disease Control and Prevention. US Public Health Service"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad060\/49121601\/ofad060.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/3\/ofad060\/49601443\/ofad060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/3\/ofad060\/49601443\/ofad060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T13:20:22Z","timestamp":1679664022000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad060\/7031077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad060","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,2,8]]},"article-number":"ofad060"}}